SUMMIT
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
AI Description
Prospective, controlled, multicenter clinical investigation with four trial cohorts: Randomized, Non-repairable, Severe Mitral Annular Calcification (MAC) and Severe Mitral Annular Calcification Continued Access Plan (MAC CAP). Subjects in the Randomized cohort were randomized in a 1:1 ratio to the trial device or to the MitraClip system. Subjects in the Non-repairable, Severe MAC, and Severe MAC CAP cohorts were receive the trial device.
The objective of the Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation (SUMMIT) was to evaluate the safety and effectiveness of the Tendyne Transcatheter Mitral Valve System for the treatment of patients with symptomatic, moderate-to-severe or severe mitral regurgitation or for patients with symptomatic mitral valve disease due to severe mitral annular calcification.
This randomized controlled trial would provide the opportunity to evaluate the safety and clinical benefits of the Tendyne Transcatheter Mitral Valve System compared to the MitraClip System in patients with symptomatic, moderate-to-severe or severe mitral regurgitation, within approved MitraClip indications. In addition, the safety and effectiveness of the Tendyne Transcatheter Mitral Valve System would be evaluated in patients with severe mitral annular calcification who are at prohibitive risk for mitral valve surgery. Patients who were not suitable for mitral valve surgery for reasons other than severe mitral annular calcification and were also not suitable for transcatheter repair with MitraClip, would be enrolled in the Non-repairable cohort.
Subjects would be seen at screening, pre- and post-procedure, discharge, 30 days, 3 months, 6 months, and annually through 5 years.
- Who can join
- adult, older adult
- Participants
- 103
- Expected completion
- 2028-06
- Funded by
- industry
Conditions studied
Cardiovascular Diseases, Degenerative Mitral Valve Disease, Functional Mitral Regurgitation, Heart Valve Diseases, Mitral Insufficiency, Mitral Regurgitation, Mitral Valve Insufficiency, Valve Disease, Heart
What is being tested
- DEVICE: MitraClip System
- DEVICE: Tendyne Mitral Valve System
What it measures
- Percentage of Participants With Freedom From All-cause Mortality and Heart Failure Hospitalization (HFH), The primary endpoint for the Severe MAC cohort is freedom from all-cause mortality and heart failure hospitalization (HFH), evaluated against a performance goal of 43%., 12 months post index procedure
Centers Participating
These centers are participating in this study. Reach out to them directly to learn more.
Abbott Northwestern Hospital
Minneapolis, MN
Adventist HealthCare White Oak Medical Center
Silver Spring, MD
Advocate Christ Medical Center (Oak Lawn)
Oak Lawn, IL
Albany Medical Center
Albany, NY
Allegheny General Hospital
Pittsburgh, PA
Ascension Saint Thomas Hospital
Nashville, TN
Ascension Via Christi (Wichita)
Wichita, KS
Atrium Health Carolinas Medical Center
Charlotte, NC
Banner – University Medical Center Phoenix
Phoenix, AZ
Baptist Health Medical Center-Little Rock
Little Rock, AR
Baptist Hospital (Miami)
Miami, FL
Baptist Memorial Hospital-Memphis
Memphis, TN
Baylor Scott & White The Heart Hospital – Dallas
Dallas, TX
Cardiology P.C
Birmingham, AL
Cardiovascular Consultants
Springfield, IL
Cedars-Sinai Medical Center
Los Angeles, CA
Centennial Heart
Nashville, TN
Cleveland Clinic
Cleveland, OH
Cleveland Clinic Weston Hospital
Weston, FL
Delray Medical Center
Delray Beach, FL
Emory University Hospital
Atlanta, GA
Froedtert Hospital
Milwaukee, WI
Hackensack University Medical Center
Hackensack, NJ
HCA Florida North Florida Hospital
Gainesville, FL
Henry Ford Health (Detroit)
Detroit, MI
HonorHealth Scottsdale Shea Medical Center
Scottsdale, AZ
Inova Fairfax Medical Campus
Falls Church, VA
J.W. Ruby Memorial Hospital
Morgantown, WV
Kaleida Health
Buffalo, NY
Keck Hospital of USC
Los Angeles, CA
Lenox Hill Hospital
New York, NY
Los Robles Regional Medical Center
Thousand Oaks, CA
Manatee Memorial Hospital
Bradenton, FL
Mayo Clinic (Rochester, Minnesota)
Rochester, MN
Medical City Heart Hospital (Dallas)
Dallas, TX
MedStar Union Memorial Hospital
Baltimore, MD
Memorial Hermann-Texas Medical Center
Houston, TX
Michigan Medicine Cardiovascular Center
Ann Arbor, MI
Mission Hospital (Asheville)
Asheville, NC
Morton Plant Hospital (Clearwater)
Clearwater, FL
MUSC Health
Charleston, SC
New England Heart and Vascular Institute
Manchester, NH
Newark Beth Israel Medical Center
Newark, NJ
NewYork-Presbyterian Hospital
New York, NY
Novant Health Presbyterian Medical Center
Charlotte, NC
Oklahoma Heart Hospital
Tulsa, OK
Piedmont Atlanta Hospital
Atlanta, GA
Providence St. Patrick Hospital
Missoula, MT
Providence St. Vincent Medical Center
Portland, OR
Robert Wood Johnson University Hospital
New Brunswick, NJ
Rush University Medical Center
Chicago, IL
Saint Alphonsus Regional Medical Center
Boise, ID
Saint Luke’s Hospital of Kansas City
Kansas City, MO
Sharp Memorial Hospital
San Diego, CA
South Shore University Hospital (Bay Shore)
Bay Shore, NY
SSM Health Saint Louis University Hospital
Saint Louis, MO
St. David's Medical Center
Austin, TX
Stanford Health Care
Stanford, CA
Sutter Medical Center, Sacramento
Sacramento, CA
Swedish Cherry Hill Campus
Seattle, WA
Tallahassee Memorial HealthCare
Tallahassee, FL
UAB Hospital
Birmingham, AL
UC Davis Medical Center
Sacramento, CA
UCSF Health
San Francisco, CA
UF Health Shands Hospital
Gainesville, FL
University Medical Center
Charlottesville, VA
University of Cincinnati Medical Center
Cincinnati, OH
University of Colorado Hospital
Aurora, CO
University of Maryland Medical Center
Baltimore, MD
UPMC Presbyterian Shadyside
Pittsburgh, PA
Wellstar Kennestone Regional Medical Center
Marietta, GA
Registry entry updated 2026-07-23
Deciding whether to join a study is your choice, and you can ask a study team questions before you decide anything.